Aurora Cannabis

Global CBD Consumers Continue to Gain More Offerings as Market Regulations Around the World Solidify

Retrieved on: 
Wednesday, February 17, 2021
Herbalism, Medicinal plants, Health sciences, Branches of biology, Aurora Cannabis, Cannabis in Alberta, Medicine, CBD, Medical cannabis, Cannabis, Consumer

A new bipartisan bill is currently being reintroduced to the US congress , while the European CBD market is already projected to grow 400% through 2023.

Key Points: 
  • A new bipartisan bill is currently being reintroduced to the US congress , while the European CBD market is already projected to grow 400% through 2023.
  • "Global consumers are becoming increasingly familiar with CBD and its potential benefits to their daily routine," added Dr. Mitchell.
  • "After conducting months of extensive consumer research, it was clear that the majority of our customers and consumers in the market are seeking products with increased CBD percentages.
  • Last year, Aurora Cannabis (NYSE:ACB) (TSX:ACB) made headlines when it made a CBD deal to enter the lucrative US market.

Cannabis Market worth $90.4 billion by 2026 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Monday, February 8, 2021
Medicinal plants, Cannabis, Health, Medicine, Entheogens, Euphoriants, Cannabis smoking, Herbalism, Effects of cannabis, Medical cannabis, Cannabis in Canada, Aurora Cannabis

It is projected to reach USD 90.4 billion by 2026, recording a CAGR of 28.0%, in terms of value.

Key Points: 
  • It is projected to reach USD 90.4 billion by 2026, recording a CAGR of 28.0%, in terms of value.
  • The growing medical applications of cannabis is driving the demand for cannabis.
  • CBD-dominant segment accounted for the second-largest market share in the overall Cannabis Market.
  • Along with this, the demand for medical cannabis is rising in the region, further fueling the growth of European Cannabis Market.

Cannabis Market worth $90.4 billion by 2026 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Monday, February 8, 2021
Medicinal plants, Cannabis, Health, Medicine, Entheogens, Euphoriants, Cannabis smoking, Herbalism, Effects of cannabis, Medical cannabis, Cannabis in Canada, Aurora Cannabis

It is projected to reach USD 90.4 billion by 2026, recording a CAGR of 28.0%, in terms of value.

Key Points: 
  • It is projected to reach USD 90.4 billion by 2026, recording a CAGR of 28.0%, in terms of value.
  • The growing medical applications of cannabis is driving the demand for cannabis.
  • CBD-dominant segment accounted for the second-largest market share in the overall Cannabis Market.
  • Along with this, the demand for medical cannabis is rising in the region, further fueling the growth of European Cannabis Market.

Aurora Cannabis to Host Second Quarter Fiscal Year 2021 Investor Conference Call

Retrieved on: 
Thursday, January 28, 2021
Cannabis, Health sciences, Cannabis in Saskatchewan, CanniMed, Aurora, Illinois, Medical cannabis, Medicine, Aurora Cannabis

Headquartered in Edmonton, Alberta, Aurora is a pioneer in global cannabis dedicated to helping people improve their lives.

Key Points: 
  • Headquartered in Edmonton, Alberta, Aurora is a pioneer in global cannabis dedicated to helping people improve their lives.
  • The Company's brand portfolio includes Aurora, Aurora Drift, San Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, and Reliva CBD.
  • Providing customers with innovative, high-quality cannabis products, Aurora's brands continue to break through as industry leaders in the medical, performance, wellness and recreational markets wherever they are launched.
  • This news release includes statements containing certain "forward-looking information" within the meaning of applicable securities law ("forward-looking statements").

Aurora Cannabis Closes Previously Announced Bought Deal Financing

Retrieved on: 
Tuesday, January 26, 2021
Cannabis in Alberta, Aurora Cannabis, Psychoactive drugs, Cannabis, CanniMed, Aurora Publishing, Aurora, Illinois, Legality of cannabis

EDMONTON, Alberta, Jan. 26, 2021 (GLOBE NEWSWIRE) -- Aurora Cannabis Inc. (the Company or Aurora) (NYSE | TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today the closing of its previously announced bought deal public offering (the Offering) of units of the Company (the Units) for total gross proceeds of US$137,940,000.

Key Points: 
  • EDMONTON, Alberta, Jan. 26, 2021 (GLOBE NEWSWIRE) -- Aurora Cannabis Inc. (the Company or Aurora) (NYSE | TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today the closing of its previously announced bought deal public offering (the Offering) of units of the Company (the Units) for total gross proceeds of US$137,940,000.
  • Aurora is a global leader in the cannabis industry serving both the medical and consumer markets.
  • Headquartered in Edmonton, Alberta, Aurora is a pioneer in global cannabis dedicated to helping people improve their lives.
  • The Companys brand portfolio includes Aurora, Aurora Drift, San Rafael 71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, and Reliva CBD.

Australis Provides Update With Respect to Australian Cannabis Grow Facility Contract

Retrieved on: 
Tuesday, January 26, 2021
Health sciences, Aurora Cannabis, Cannabis in Alberta, Medical cannabis, Medicine, Health care

This provides a competitive advantage and has resulted in many cannabis companies seeking out ALPS for their new facility initiatives.

Key Points: 
  • This provides a competitive advantage and has resulted in many cannabis companies seeking out ALPS for their new facility initiatives.
  • APIS also delivers significant value outside of regulated industries through optimization of facility operations including preventative maintenance and KPI tracking.
  • Thomas Larssen, President of ALPS, stated, "This is a significant contract for us in terms of size, and acknowledges the respect ALPS has garnered in the global cannabis space.
  • The ALPS deal includes Terry Booth, founder and ex-CEO of Aurora Cannabis taking the reins of CEO for Australis.

An Expanding Legal Marketplace Fosters Innovation in the Cannabis Industry

Retrieved on: 
Wednesday, January 20, 2021
Cannabis, Herbalism, Medicinal plants, Cannabis smoking, Psychoactive drugs, Health sciences, Aurora Cannabis, Cannabis in Alberta, Medical cannabis, Effects of cannabis, Cannabis in Canada

Customers are now choosing to legally purchase cannabis products for medical as well as adult use.

Key Points: 
  • Customers are now choosing to legally purchase cannabis products for medical as well as adult use.
  • The revenue generated from these taxes could encourage local governments to fund several development programs for education and infrastructure.
  • Aurora Cannabis Inc.(NYSE: ACB) announced in November that it has entered into a strategic Supply Agreement with Cantek Holdings, one of Israel's leaders in the medical cannabis field.
  • You agree to consult with your investment advisor, tax and legal consultant before making any investment decisions.

An Expanding Legal Marketplace Fosters Innovation in the Cannabis Industry

Retrieved on: 
Wednesday, January 20, 2021
Cannabis, Herbalism, Medicinal plants, Cannabis smoking, Psychoactive drugs, Health sciences, Aurora Cannabis, Cannabis in Alberta, Medical cannabis, Effects of cannabis, Cannabis in Canada

Customers are now choosing to legally purchase cannabis products for medical as well as adult use.

Key Points: 
  • Customers are now choosing to legally purchase cannabis products for medical as well as adult use.
  • The revenue generated from these taxes could encourage local governments to fund several development programs for education and infrastructure.
  • Aurora Cannabis Inc.(NYSE: ACB) announced in November that it has entered into a strategic Supply Agreement with Cantek Holdings, one of Israel's leaders in the medical cannabis field.
  • You agree to consult with your investment advisor, tax and legal consultant before making any investment decisions.

Aurora Announces Agreement with Great North Distributors Inc. For Canadian Retail Sales Execution

Retrieved on: 
Thursday, January 14, 2021
Medicinal plants, Entheogens, Euphoriants, Herbalism, Health sciences, Cannabis, Branches of biology, Aurora Cannabis, Cannabis in Alberta, Medical cannabis, Canopy Growth

Under the agreement, Great North will be the exclusive representative for Aurora's leading portfolio of brands across the Canadian cannabis retail environment.

Key Points: 
  • Under the agreement, Great North will be the exclusive representative for Aurora's leading portfolio of brands across the Canadian cannabis retail environment.
  • Great North brings deep experience across the spectrum of sales capabilities that will further differentiate Aurora as a leader in the growing cannabis space," said Miguel Martin, CEO, Aurora Cannabis.
  • Great North applies industry-leading data analytics capabilities to the sector, providing suppliers with a powerful data-driven approach to cannabis sales.
  • "Great North has executed in the Canadian cannabis market since day one and will immediately bring value in sales execution to Aurora.

Australis Enters Into Term Sheet to Acquire ALPS

Retrieved on: 
Wednesday, January 6, 2021
Medicinal plants, Herbalism, Entheogens, Euphoriants, Herbs, Health sciences, Branches of biology, Psychoactive drugs, Aurora Cannabis, Legality of cannabis, Medical cannabis, Cannabis

It is anticipated that ALPS licensed cultivation partners will grow AUSA-owned and branded cultivars such as Mr. Natural and Green Therapeutics.

Key Points: 
  • It is anticipated that ALPS licensed cultivation partners will grow AUSA-owned and branded cultivars such as Mr. Natural and Green Therapeutics.
  • Since its May 2020 management buy-out from Aurora Cannabis, ALPS has rapidly built up an impressive pipeline of committed projects and recurring service contracts.
  • Longer term, the potential legalization of cannabis at the U.S. federal level is likely to create demand for massive-scale, centralized cultivation facilities, in which ALPS is the undisputed world leader.
  • ALPS' new compliance and data-driven service offering, APIS, is designed to create a high-margin, recurring revenue stream.